Due to the beneficial effect on glycemic control, several GLP-1 analogs and GLP-1 receptor agonists (GLP-1RA), resistant to the DPP-4 action, were developed and received approval for use in the treatment of T2DM. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.